Correction: Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade

Related Posts

• Correction: JAK inhibitors and COVID-19

• PD-L1 Expression Predicts Efficacy of PD-1/PD-L1 Inhibitors in Metastatic TNBC

  KEY TAKEAWAYS The phase 3 IMPassion131 trial aimed to analyze the prognostic significance of PD-L1…

• Efficacy of PD-1 Inhibitors With nCRT in LARC

  KEY TAKEAWAYS The study aimed to investigate the efficacy and safety of PD-1/PD-L1 inhibitors combined…